Total Infectome Characterization of Eye Infections

Launched by SHANGHAI GENERAL HOSPITAL, SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE · Jan 9, 2025

Keywords

ClinConnect Summary

This clinical trial, titled "Total Infectome Characterization of Eye Infections," is studying the various infections that can affect the eyes, particularly those caused by different viruses like Mpox, Zika, Ebola, and SARS-CoV-2. The goal is to better understand all the possible pathogens (germs) that can cause eye infections by collecting and analyzing samples from patients. This study is important because it aims to improve how we diagnose and treat these infections, especially as new viral threats emerge.

To be eligible for this study, participants should have a diagnosed eye infection such as conjunctivitis (pink eye), keratitis (inflammation of the cornea), uveitis (inflammation inside the eye), or endophthalmitis (infection inside the eye). Additionally, they need to have biological samples that can be examined for research purposes. If you choose to participate, you will be contributing to important research that could help improve eye infection treatments. The trial is currently looking for participants of all ages and genders, and your involvement could help advance our understanding of these infections.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Patients with a clinical diagnosis of one or more types of eye infections (including acute conjunctivitis, keratitis, uveitis, and endophthalmitis).
• • 2. Biological samples has been collected for clinical microbiological examination, or consented to participate in this study.
• Exclusion Criteria:
• • 1. Patients who have no historically clinical surplus specimens.